Research graph
References from Azithromycin is First-line Therapy for Atypical Coverage of Severe Community-Acquired Pneumonia. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America
10.1164/rccm.201908-1581st · 2019 · External reference
Active bacterial core surveillance for legionellosis - United States, 2011-2013
10.15585/mmwr.mm6442a2 · 2015 · External reference
Mycoplasma pneumoniae infections in hospitalized children — United States, 2018–2024
10.15585/mmwr.mm7423a1 · 2025 · External reference
Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams: a multicenter matched cohort study
10.1093/cid/ciaf252 · 2026 · External reference
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions
10.1093/jac/dkh519 · 2005 · External reference
Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection
10.2169/internalmedicine.48.1482 · 2009 · External reference
The cardiotoxicity of macrolides: a systematic review
10.31083/ph.2010.0644 · 2010 · External reference
Azithromycin and the risk of cardiovascular death
10.1056/nejmoa1003833 · 2012 · External reference
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia
10.1001/jama.2014.4304 · 2014 · External reference
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia
10.1001/jama.2014.4304 · ExternalCitation · doi-reference
Azithromycin and the risk of cardiovascular death
10.1056/nejmoa1003833 · ExternalCitation · doi-reference
Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams: a multicenter matched cohort study
10.1093/cid/ciaf252 · ExternalCitation · doi-reference
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions
10.1093/jac/dkh519 · ExternalCitation · doi-reference
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America
10.1164/rccm.201908-1581st · ExternalCitation · doi-reference
Active bacterial core surveillance for legionellosis - United States, 2011-2013
10.15585/mmwr.mm6442a2 · ExternalCitation · doi-reference
Mycoplasma pneumoniae infections in hospitalized children — United States, 2018–2024
10.15585/mmwr.mm7423a1 · ExternalCitation · doi-reference
Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection
10.2169/internalmedicine.48.1482 · ExternalCitation · doi-reference
The cardiotoxicity of macrolides: a systematic review
10.31083/ph.2010.0644 · ExternalCitation · doi-reference
